Chief Financial Officer
Chief Financial Officer at Apogee Therapeutics, Inc., filing insider transactions between 2026-03-02 and 2026-05-01.
| SEC ↗ |
| 2026-04-16 | APGE | Sale | 2,000 | $90.00 | $180K | SEC ↗ |
| 2026-04-01 | APGE | Sale | 1,100 | $85.46 | $94K | SEC ↗ |
| 2026-04-01 | APGE | Sale | 900 | $84.46 | $76K | SEC ↗ |
| 2026-03-25 | APGE | Sale | 2,000 | $85.00 | $170K | SEC ↗ |
| 2026-03-02 | APGE | Sale | 300 | $69.43 | $21K | SEC ↗ |
| 2026-03-02 | APGE | Sale | 994 | $70.45 | $70K | SEC ↗ |
| 2026-03-02 | APGE | Sale | 406 | $71.66 | $29K | SEC ↗ |
| 2026-03-02 | APGE | Sale | 300 | $68.27 | $20K | SEC ↗ |